Prospective observational study on the impact of vaccination against COVID-19 in patients with hematopoietic tumors
Not Applicable
- Conditions
- hematopoietic tumors
- Registration Number
- JPRN-UMIN000049407
- Lead Sponsor
- ational cancer center hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects whom the principal investigator or physician in charge determines are not appropriate for this study 2) Patients after allogeneic hematopoietic stem cell transplantation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SARS-CoV-2 antibody positivity after vaccination
- Secondary Outcome Measures
Name Time Method